The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk.
about
ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary studyPAH-DNA adducts in a Chinese population: relationship to PAH exposure, smoking and polymorphisms of metabolic and DNA repair genesGenetic variation in nucleotide excision repair pathway genes influence prostate and bladder cancer susceptibility in North Indian populationGerm line variation in nucleotide excision repair genes and lung cancer risk in smokersPolymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in TaiwanDNA and protein adducts in human tissues resulting from exposure to tobacco smokeJapanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics.Single nucleotide polymorphisms in DNA repair genes and prostate cancer riskMolecular epidemiology of DNA repair gene polymorphisms and head and neck cancer.Nucleotide excision repair gene polymorphisms, meat intake and colon cancer riskCauses of genome instability: the effect of low dose chemical exposures in modern societyGenetic polymorphisms in RAD23B and XPC modulate DNA repair capacity and breast cancer risk in Puerto Rican womenPolymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New HampshirePolymorphisms in DNA damage response genes and head and neck cancer riskGenetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis.Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern SpainDo genetic factors protect for early onset lung cancer? A case control study before the age of 50 years.ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking femalesRelationship between XPD Lys 751 Gln polymorphism and colorectal cancer risk: a case-control study in a population-based studyPolymorphisms of DNA repair genes OGG1 and XPD and the risk of age-related cataract in Egyptians.Lung cancer risk and genetic polymorphisms in DNA repair pathways: a meta-analysis.Variability in human sensitivity to 1,3-butadiene: influence of polymorphisms in the 5'-flanking region of the microsomal epoxide hydrolase gene (EPHX1).Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.Meat-derived carcinogens, genetic susceptibility and colorectal adenoma riskAssociations between XPD Asp312Asn polymorphism and risk of head and neck cancer: a meta-analysis based on 7,122 subjects.Effect of occupational exposure to cytostatics and nucleotide excision repair polymorphism on chromosomal aberrations frequency.DNA Repair Gene Polymorphisms in the Nucleotide Excision Repair Pathway and Lung Cancer Risk: A Meta-analysis.BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer.ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes.Smoking and selected DNA repair gene polymorphisms in controls: systematic review and meta-analysisAssociation between polymorphisms in ERCC2 gene and oral cancer risk: evidence from a meta-analysis.The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk.Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysisPolymorphisms of phase II xenobiotic-metabolizing and DNA repair genes and in vitro N-ethyl-N-nitrosourea-induced O6-ethylguanine levels in human lymphocytes.Susceptibility of XPD and RAD51 genetic variants to carcinoma of urinary bladder in North Indian populationERCC1 and ERCC2 polymorphisms and adult glioma.Pharmacogenomics and stomach cancer.XPD Lys751Gln increases the risk of breast cancerThe Nucleotide Excision Repair Pathway Limits L1 RetrotranspositionERCC1 intron 1 was associated with breast cancer risk.
P2860
Q21260394-01CA41B4-9E7D-419F-8896-03A6B4D739D4Q23924098-204C5F35-902E-4BF3-8DEC-9592B7F02E11Q24596628-55395B72-3E72-42BD-92EC-F06106EF57B0Q24607290-49065A74-3E3E-4996-898F-5C1332FBE4F7Q24805138-23307689-A59B-4398-A93A-A90BA2FC07D3Q27021044-2BF32883-434F-43A6-A47D-16EBE6FF19ECQ27851471-FB526D32-FC2D-4BC3-9BC9-C94197C19B29Q28383002-A54FD425-CDF5-4A48-B38A-1BFC1A80D77BQ28383483-E49D6818-31E4-4021-AF31-5632887A3016Q28387797-1DD9F9F3-1EEE-4A20-BBD7-D834557C05CCQ28388277-1D96E70E-1FA2-444C-8634-2B77C65CEA32Q28390577-4C79DA49-1996-445D-B2A3-9E65D181A108Q28396452-FDE8353A-4343-47F5-BC48-A77694390F23Q28397205-237610BC-4E55-4F3A-9B18-B086172296A0Q30829689-B441296B-372E-47B5-A225-B051083E3958Q33294473-F7E5EDAC-C3D3-40DD-898A-BB73DE14FFFAQ33321041-4C3A8CED-0E5C-445C-94AB-D8809A92F7B8Q33555896-2D2C1DD8-2947-493D-A77C-DA2F4F19A73EQ33596523-5F91D9BD-710B-4206-B701-156F546B5CE1Q33643996-7F6EAA07-E743-4A85-8B8F-5BD4846A522BQ33730235-96959BFE-2160-4176-8252-0FF62C6544CBQ33881729-9D959EF2-8B5D-4907-B6C0-12017D188F5EQ33985880-403325E6-BC89-418A-B34F-94DD9CD9C3E7Q34200101-29FA58CC-DF26-487E-8F54-9EF1566FA9D5Q34247170-178C9A68-F347-4BA1-99FC-8D452273CD56Q34320010-A2DBC990-D69C-4D3C-983F-A5560753ACA2Q34617926-005BB696-7544-4BBC-9D2F-3529EBF941EEQ34621524-5F8FBFBB-6777-4102-ACBB-2427DA27B025Q34672604-CBB7E14B-3838-40BA-B6D3-7C24E1C40706Q35025806-9A03C6CB-0134-4BFB-8C80-045E548BEDAAQ35065281-6A8C7CD9-075C-45FE-871B-CAA28548A32FQ35510411-83E146A0-02D2-4EC0-99FD-9542139F5658Q35535254-3D1A05E8-CC29-485B-9E69-83AF44D0A5A8Q35688348-C2DA37B2-5B78-4F33-AE9B-4581FB0926C1Q35737487-E3C93776-9B16-4CB8-A4EC-530FDFC6DBDBQ35800114-6A6CA6AC-2092-4D2D-A346-868B8E2C62D6Q35873676-F029831B-9039-4115-91FF-D1B8DD952293Q36142356-A5A05E50-7252-4C52-B476-E7FD539C195FQ36239040-3ECA7D3F-6EB8-4A4B-B13A-8886B770D10FQ36286297-9FC23661-1988-4998-8651-962571183024
P2860
The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The XPD variant alleles are as ...... ct level and lung cancer risk.
@ast
The XPD variant alleles are as ...... ct level and lung cancer risk.
@en
The XPD variant alleles are as ...... ct level and lung cancer risk.
@nl
type
label
The XPD variant alleles are as ...... ct level and lung cancer risk.
@ast
The XPD variant alleles are as ...... ct level and lung cancer risk.
@en
The XPD variant alleles are as ...... ct level and lung cancer risk.
@nl
prefLabel
The XPD variant alleles are as ...... ct level and lung cancer risk.
@ast
The XPD variant alleles are as ...... ct level and lung cancer risk.
@en
The XPD variant alleles are as ...... ct level and lung cancer risk.
@nl
P2093
P356
P1433
P1476
The XPD variant alleles are as ...... ct level and lung cancer risk.
@en
P2093
Bo Lambert
Fredrik Nyberg
Sabrina Angelini
Sai-Mei Hou
Susann Fält
P304
P356
10.1093/CARCIN/23.4.599
P407
P577
2002-04-01T00:00:00Z